Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Operating Margin (2021 - 2025)

Historic Operating Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 23682.56%.

  • Pulse Biosciences' Operating Margin changed N/A to 23682.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 91798.84%, marking a year-over-year change of. This contributed to the annual value of 8293.86% for FY2022, which is 38499900.0% down from last year.
  • Latest data reveals that Pulse Biosciences reported Operating Margin of 23682.56% as of Q3 2025.
  • Pulse Biosciences' 5-year Operating Margin high stood at 97166.67% for Q4 2022, and its period low was 23682.56% during Q3 2025.
  • In the last 3 years, Pulse Biosciences' Operating Margin had a median value of 3188.45% in 2022 and averaged 10101.67%.
  • Over the last 5 years, Pulse Biosciences' Operating Margin had its largest YoY gain of 989925000bps in 2022, and its largest YoY loss of 989925000bps in 2022.
  • Over the past 3 years, Pulse Biosciences' Operating Margin (Quarter) stood at 1825.83% in 2021, then soared by 5422bps to 97166.67% in 2022, then plummeted by -124bps to 23682.56% in 2025.
  • Its Operating Margin was 23682.56% in Q3 2025, compared to 97166.67% in Q4 2022 and 4671.33% in Q2 2022.